As of Feb 27
| +0.84 / +2.10%|
The 28 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 39.75, with a high estimate of 47.13 and a low estimate of 28.39. The median estimate represents a -2.47% decrease from the last price of 40.76.
The current consensus among 32 polled investment analysts is to Hold stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.